GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma

The aim of dendritic cell (DC) vaccination in cancer is to induce tumor-specific effector T cells that may reduce and control tumor mass. Immunostimulants that could drive a desired immune response are necessary to be found in order to generate a long lasting tumor immune response. GK-1 peptide, der...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunol Res
Autors principals: Piñón-Zárate, Gabriela, Herrera-Enríquez, Miguel Ángel, Hernández-Téllez, Beatriz, Jarquín-Yáñez, Katia, Castell-Rodríguez, Andrés Eliú
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4230216/
https://ncbi.nlm.nih.gov/pubmed/25759825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/158980
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars